tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NBIX is currently covered by 20 analysts with an average price target of $161.4. This is a potential upside of $33.72 (26.41%) from yesterday's end of day stock price of $127.68.
Neurocrine Biosciences's activity chart (see below) currently has 489 price targets and 361 ratings on display. The stock rating distribution of NBIX is 93.1% BUY and 6.9% HOLD.
Analysts average stock forecasts to be materialized ratio is 72.12% with an average time for these price targets to be met of 251.89 days.
Highest price target for NBIX is $204, Lowest price target is $140, average price target is $172.75.
Most recent stock forecast was given by ANUPAM RAMA from JPMORGAN on 12-Mar-2026. First documented stock forecast 04-Feb-2015.
Currently out of the existing stock ratings of NBIX, 54 are a BUY (93.1%), 4 are a HOLD (6.9%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Nov-2021
$177
$49.32 (38.63%)
$176
9 days ago
(12-Mar-2026)
15/22 (68.18%)
$49.22 (38.52%)
332
Buy Since 01-Feb-2021
$140
$12.32 (9.65%)
$169
1 months 4 days ago
(17-Feb-2026)
4/9 (44.44%)
$12.24 (9.58%)
529
Buy Since 23-Apr-2024
$175
$47.32 (37.06%)
$170
1 months 8 days ago
(13-Feb-2026)
5/7 (71.43%)
$50.88 (40.99%)
57
Buy Since 21-Oct-2025
$204
$76.32 (59.77%)
$203
1 months 9 days ago
(12-Feb-2026)
0/3 (0%)
$80.9 (65.72%)
Buy Since 14-Apr-2025
$177
$49.32 (38.63%)
$160
1 months 9 days ago
(12-Feb-2026)
25/28 (89.29%)
$53.9 (43.79%)
127
What is NBIX (Neurocrine Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?
Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?
Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?
